A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma

Bohong Chen; Mingguo Zhou; Li Guo; Xinyue Sun; Haoxiang Huang; Kaijie Wu; Wei Chen; Dapeng Wu

doi:doi:10.18632/aging.205916

← Back

Research Paper Volume 16, Issue 11 pp 10033—10062

A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma

Figure 4. Genomic alterations in disulfidptosis-related signatures. Genomic profiling of the 20 most frequently altered genes in the DC1 (A) and DC2 (B) groups. (C) Comparison of MATH score between the two ccRCC subtypes. (D) Comparison of the TMB levels between the two ccRCC subtypes.